We are live on
!
Find out more
MWNA
Marshall Wace North America Portfolio holdings
AUM
$23.5B
1-Year Est. Return
46.46%
This Fund
S&P 500
This Quarter
Est. Return
+9.25%
1 Year Est. Return
+46.46%
3 Year Est. Return
+108.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$12.7B
AUM Growth
–
Cap. Flow
+$12.4B
Cap. Flow
% of AUM
97.73%
Top 10 Holdings %
Top 10 Hldgs %
14.47%
Holding
941
New
941
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$282M |
| 2 |
Zoetis
ZTS
|
+$249M |
| 3 |
Amazon
AMZN
|
+$233M |
| 4 |
Meta Platforms (Facebook)
META
|
+$178M |
| 5 |
S&P Global
SPGI
|
+$161M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.78% |
| 2 | Technology | 16.8% |
| 3 | Consumer Discretionary | 11.26% |
| 4 | Industrials | 9.92% |
| 5 | Communication Services | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WBC
76
DELISTED
WABCO HOLDINGS INC.
WBC
| $47.3M | 0.37% |
+404,607
| New | +$45.5M |
|
77
Cooper Companies
COO
$14.6B
| $46.9M | 0.37% |
+937,700
| New | +$44.5M |
|
|
HDS
78
DELISTED
HD Supply Holdings, Inc.
HDS
| $46.4M | 0.37% |
+1,132,742
| New | +$47.9M |
|
79
Vertex Pharmaceuticals
VRTX
$124B
| $46.3M | 0.37% |
+424,563
| New | +$37.4M |
|
|
ATVI
80
DELISTED
Activision Blizzard
ATVI
| $45.1M | 0.36% |
+901,663
| New | +$39.6M |
|
81
Incyte
INCY
$24.6B
| $44.9M | 0.35% |
+335,378
| New | +$42.7M |
|
82
Comcast
CMCSA
$87.1B
| $43.3M | 0.34% |
+1,139,794
| New | +$42.3M |
|
83
McDonald's
MCD
$195B
| $42.9M | 0.34% |
+330,166
| New | +$41.4M |
|
84
Teleflex
TFX
$6.2B
| $42.4M | 0.33% |
+218,393
| New | +$39.3M |
|
|
MXIM
85
DELISTED
Maxim Integrated Products
MXIM
| $41.9M | 0.33% |
+930,534
| New | +$40.8M |
|
86
Visa
V
$689B
| $41.1M | 0.32% |
+461,550
| New | +$39.7M |
|
87
Zebra Technologies
ZBRA
$17.5B
| $41M | 0.32% |
+451,075
| New | +$39.1M |
|
88
Omnicom Group
OMC
$22.8B
| $40.2M | 0.32% |
+467,468
| New | +$39.9M |
|
89
Air Products & Chemicals
APD
$65.6B
| $39.6M | 0.31% |
+293,506
| New | +$41.4M |
|
90
Charles River Laboratories
CRL
$12.6B
| $39.4M | 0.31% |
+437,279
| New | +$37.1M |
|
91
Axalta
AXTA
$8.14B
| $38.6M | 0.3% |
+1,207,100
| New | +$35.9M |
|
92
Zimmer Biomet
ZBH
$19.3B
| $38.6M | 0.3% |
+326,065
| New | +$37M |
|
93
Biogen
BIIB
$30.9B
| $38.4M | 0.3% |
+140,709
| New | +$39.8M |
|
94
Ollie's Bargain Outlet
OLLI
$4.77B
| $38.2M | 0.3% |
+1,124,358
| New | +$35.4M |
|
95
Hyatt Hotels
H
$17B
| $37.9M | 0.3% |
+701,115
| New | +$37.8M |
|
|
SYNH
96
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $37.6M | 0.3% |
+818,132
| New | +$40.7M |
|
97
Yum China
YUMC
$16.4B
| $37.6M | 0.3% |
+1,392,021
| New | +$37.2M |
|
98
BioMarin Pharmaceuticals
BMRN
$11.7B
| $37.4M | 0.3% |
+425,183
| New | +$37.8M |
|
|
IPG
99
DELISTED
Interpublic Group of Companies
IPG
| $37.4M | 0.29% |
+1,494,998
| New | +$35.9M |
|
100
Regions Financial
RF
$27.4B
| $37.3M | 0.29% |
+2,487,143
| New | +$36.7M |
|
Similar funds
TGHSA
PAM
HB
MWA
3SCA
HFCIV
DVC
NAM
Marshall Wace North America's Q1 2017 Portfolio in Review
Q1 2017 is the first quarter with a 13F filing on record for Marshall Wace North America, which disclosed 941 positions worth $12.7B. Its ten largest holdings account for 14% of the portfolio.
Its largest position is T-Mobile US: 4,584,723 shares worth $298M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, followed by Technology and Consumer Discretionary.
- Marshall Wace North America's largest Q1 2017 buy was T-Mobile US: 4,584,723 shares worth $298M.
- Marshall Wace North America's ten largest holdings make up 14% of its $12.7B portfolio in Q1 2017.
- Marshall Wace North America disclosed 941 positions in Q1 2017, its first 13F filing on record.
Based on Marshall Wace North America's 13F filing for Q1 2017, filed 12 May 2017.